Literature DB >> 16685003

Causes and clinical features of subacute cough.

Nam-Hee Kwon1, Mi-Jung Oh, Tae-Hoon Min, Byung-Jae Lee, Dong-Chull Choi.   

Abstract

STUDY
OBJECTIVES: Cough lasting > 3 weeks has been defined as chronic cough. However, it might be more persuasive to divide cough into subacute, lasting 3 to 8 weeks, and chronic, lasting > 8 weeks. We evaluated the causes and clinical courses of subacute cough, and the value of the bronchoprovocation test and induced sputum examination (IS).
METHODS: Nonsmoking patients with cough of 3 to 8 weeks duration were enrolled into the study. Patients with dyspnea, basal FEV1 of < 70% predicted, abnormal findings on a plain chest radiograph or physical examination were excluded. We prescribed an antihistamine-decongestant for patients who were suspected to have postinfectious cough or postnasal drip. If patients had positive results on a bronchoprovocation test or IS, therapy with inhaled corticosteroids was substituted according to an algorithmic approach.
RESULTS: One hundred eighty-four patients (77 men and 107 women) were evaluated; the mean age of the study group was 47.5 years. Eighty-nine of 184 patients had postinfectious cough. Cough resolved without treatment in 62 patients. Twenty-nine of 43 patients with positive bronchoprovocation test results had cough-variant asthma.
CONCLUSIONS: Postinfectious cough was the most common cause of subacute cough. The spontaneous resolution of cough was frequent in patients with subacute cough. Unless asthma was strongly suspected, the performance of the bronchoprovocation test could be delayed until after empirical treatment had been administered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685003     DOI: 10.1378/chest.129.5.1142

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

1.  A History of Recurrent Episodes of Prolonged Cough as a Predictive Value for Determining Cough Variant Asthma in a Primary Care Setting.

Authors:  Masaaki Mikami; Katsuyuki Tomita; Akira Yamasaki
Journal:  Yonago Acta Med       Date:  2021-11-29       Impact factor: 1.641

2.  Cough and asthma diagnosis: physicians' diagnosis and treatment of patients complaining of acute, subacute and chronic cough in rural areas of Japan.

Authors:  Akira Yamasaki; Keichi Hanaki; Katsuyuki Tomita; Masanari Watanabe; Yasuyuki Hasagawa; Ryota Okazaki; Miki Yamamura; Kouji Fukutani; Yuji Sugimoto; Kazuhiro Kato; Masahiro Kodani; Toshikazu Ikeda; Tatsuya Konishi; Yuji Kawasaki; Hirokazu Tokuyasu; Hiroki Yajima; Hitoshi Sejima; Takeshi Isobe; Eiji Shimizu
Journal:  Int J Gen Med       Date:  2010-04-08

3.  Treatments for subacute cough in primary care: systematic review and meta-analyses of randomised clinical trials.

Authors:  Benjamin Speich; Anja Thomer; Soheila Aghlmandi; Hannah Ewald; Andreas Zeller; Lars G Hemkens
Journal:  Br J Gen Pract       Date:  2018-09-10       Impact factor: 5.386

Review 4.  Inhaled corticosteroids for subacute and chronic cough in adults.

Authors:  Kate J Johnstone; Anne B Chang; Kwun M Fong; Rayleen V Bowman; Ian A Yang
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

5.  Fractional exhaled nitric oxide: comparison between portable devices and correlation with sputum eosinophils.

Authors:  Sehyo Yune; Jin Young Lee; Dong Chull Choi; Byung Jae Lee
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-05       Impact factor: 5.764

6.  Epidemiology of cough in relation to China.

Authors:  Kefang Lai; Jiayu Pan; Ruchong Chen; Baojuan Liu; Wei Luo; Nanshan Zhong
Journal:  Cough       Date:  2013-07-08

7.  The difficult coughing child: prolonged acute cough in children.

Authors:  Michael D Shields; Surendran Thavagnanam
Journal:  Cough       Date:  2013-04-10

8.  The efficacy of QingfengGanke granule in treating postinfectious cough in pathogenic wind invading lungs syndrome: a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Hongli Jiang; Bing Mao; Lei Wang; Ruiming Zhang; Bin She; Faguang Jin; Yanling Xu; Jian Ma; Qiuping Liu
Journal:  Chin Med       Date:  2015-08-09       Impact factor: 5.455

9.  Efficacy and safety of Qing-Feng-Gan-Ke Granules in patients with postinfectious cough: study protocol of a novel-design phase III placebo-controlled, double-blind randomized trial.

Authors:  Wei Liu; Hongli Jiang; Ruiming Zhang; Faguang Jin; Liangji Liu; Youyu Long; Liying Cui; Suyun Li; Yunqing Zhong; Bing Mao
Journal:  BMC Complement Altern Med       Date:  2015-08-19       Impact factor: 3.659

10.  Should Acid suppressive therapy improve chronic cough? (Chest 2013;143:605-612).

Authors:  Jung Hwan Oh
Journal:  J Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.